Companies are increasingly expected not only to act in compliance with the rules, but to contribute to societal and governmental resilience. Especially in the healthcare sector, this is fundamentally changing the meaning of compliance.
New regulatory requirements
With the implementation of European frameworks such as the NIS-2 Directive and the Directive on the resilience of critical entities, new requirements are emerging for companies in critical infrastructure. The focus is on:
- supply security
- business continuity
- protection of critical systems
- organisational resilience
Compliance is therefore no longer limited to avoiding rule violations. It increasingly encompasses the ability to maintain essential functions even under crisis conditions.
The BioNTech case
Against this backdrop, the BioNTech case creates a particular area of tension. The planned closure of production sites in Germany follows a business and strategic reorientation of the company. At the same time, this decision stands within the context of public expectations regarding supply security and European health resilience.
Different logics are thus in collision:
- entrepreneurial autonomy
- economic efficiency
- state resilience interests
- societal responsibility
New dimensions of conflict
The BioNTech case makes visible that compliance is increasingly operating within an expanded area of tension. This gives rise to:
- normative conflicts
- operational conflicts
- regulatory conflicts
- strategic conflicts of interest
The question is no longer exclusively whether rules are followed. It also asks: what responsibility do companies bear within critical supply structures?
Resilience compliance
The case also shows that the concept of compliance is changing. Alongside classical rule conformity, a form of “resilience compliance” is increasingly emerging – meaning active preparation to ensure the continuation of essential functions under crisis conditions.
This is precisely where goal conflicts can arise. Companies orient themselves around efficiency, market conditions and strategic transformation. State resilience logics, on the other hand, orient themselves around supply security, stability and crisis preparedness. These perspectives are not identical.
Responsibility and corporate duties
New regulatory requirements are also creating expanded demands on corporate leadership. Resilience and compliance questions are increasingly becoming part of organisational and strategic responsibility. This brings to the fore the question of how companies connect their economic decisions with societal expectations and regulatory requirements.
The decisive point
The BioNTech case does not only illustrate a single corporate decision. It points to a fundamental shift: compliance is evolving from mere rule conformity towards the question of organisational resilience.
Conclusion
The central challenge is to reconcile entrepreneurial freedom, supply security and societal responsibility. It is precisely at this intersection that the new conflicts of modern compliance systems arise.